Lycia Therapeutics
LYCA----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Lycia Therapeutics(LYCA) the EBIT is -10.44 M (+22.53%);the EPS is -0.662 (+27.82%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B22.53%
----
----
EPS
-0.662427.82%
----
----
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly